Venture Life Group plc’s Acquisition Of BBI Healthcare

In UK Allen & Overy, advised on the matter.

Allen & Overy advised Exponent Private Equity with a team including Alasdair Balfour (Competition Law), Jim Ford (IP&IT), Sarah Henchoz (Human Capital), Gordon Milne (Picture – Corporate M&A), Neil Sinha (Finance).

Exponent Private Equity agreed to sell BBI Healthcare (BBIH) to Venture Life Group plc (Venture Life).

BBIH is a division of Exponent portfolio company BBI Group and an international provider of differentiated self-care products serving women’s health, diabetes and energy management markets.

The A&O team advising Exponent is led by private equity partner Gordon Milne (Picture) with senior associate Jeremy Wilkins, associate Beth Tulley and trainee, Angela Chan. The wider A&O team included banking partners Neil Sinha and Adam Zecharia with senior associate James Green and associate Chris Watkins; TSA and IP partner Jim Ford with senior associate George Luther and associate Megan McMellon; employment: partner Sarah Henchoz with associate Stephen Brown; tax counsel Tim Harrop with associate Patrick Rohan; and antitrust partner Alasdair Balfour with senior associate David Weaver, associate Conor Slowey and trainee Alexander Westin-Hardy.

Involved fees earner: Alasdair Balfour – Allen & Overy; Stephen Brown – Allen & Overy; Jim Ford – Allen & Overy; James Green – Allen & Overy; Tim Harrop – Allen & Overy; Sarah Henchoz – Allen & Overy; George Luther – Allen & Overy; Megan McMellon – Allen & Overy; Gordon Milne – Allen & Overy; Patrick Rohan – Allen & Overy; Neil Sinha – Allen & Overy; Conor Slowey – Allen & Overy; Beth Tulley – Allen & Overy; Chris Watkins – Allen & Overy; David Weaver – Allen & Overy; Jeremy Wilkins – Allen & Overy; Adam Zecharia – Allen & Overy;

Law Firms: Allen & Overy;

Clients: Exponent Private Equity;

Author: Giulia Di Palma